Use ¡our ¡discoveries ¡to ¡advance ¡yours HTS of Ca 2+ Transients in Human iPS-derived Cardiomyocytes as a Predictive and Cost Effective Assay Early on in Drug Development Dr. Ralf Kettenhofen � Hamamatsu 10th European Functional Drug Screening Symposium � Axiogenesis AG, Cologne, Germany Actelion, Allschwil, Switzerland
Content • Introduction into the production of Cor.4U cardiomyocytes • Overview of established applications with Cor.4U cardiomyocytes • HTS calcium transient assay in the Hamamatsu FDSS/ µ Cell • Compound screening • Data analysis • Outlook 2
Generation of Cor.4U human iPS derived Cardiomyocytes • iPS generated according to Yamanaka (licensed from iPS Academia) • Production system by Axiogenesis enables large lot sizes • Tightly controlled differentiation results in minimal lot to lot variations • Selection based purification technology results in pure cardiomyocytes • Cryopreserved in various formats • GFP positive and colourless varieties will be available • Complete FTO for commercial use on the limited use label license • Cryopreserved • Fresh cultures on different substrates (cell culture flasks, 96/384 well plates) 3
4
Use ¡our ¡discoveries ¡to ¡advance ¡yours Introduction Recording of Calcium Transients in Cor.4U Cardiomyocytes
Excitation-Contraction Coupling Action Potential Currents Na + Amplitude Ca 2+ L-type Ca 2+ T-type Na + /Ca 2+ -exchanger K + I to K + IK s K + IK r Time K + IK ur Many Channel Types contribute to the Calcium is the messenger that integrates the Action Potential electrochemcial signals of the action potential with the molecular signaling pathways that regulate contraction
Hamamatsu FDSS/ µ Cell
Plating Efficiency on 384 Well Plates Fluo-4 Assay Data was kindly provided by Dr. Thomas Licher, Sanofi Germany
FDSS Parameters Analysed by the CalDio/Wave Checker Software (3) P-P duration time (1)Peak Number (2)P rate(BPM) (6) A M P (5) RMP=Fluorescence Bottom intensity at the bottom peak (7) Max_slope[Fluorescence counts/ms] same as upstroke slope AMP= Peak Fluorescence count- RMP (but bottom to peak) (8) MaxNeg_slope[Fluorescence (4)RATIO = AMP/RMP counts/ms] same as downstroke slope (but peak to bottom) (9) APD 10 to 90 (1) Peak number (total, BPM) APD10 (2) P-P time [ms] (Ave, Std, Max, Min) APD50(Peak Width, FWHM) (3) Ratio (Ave, Std) � Ratio = (AMP+RMP)/RMP A M (4) AMP (Ave, Std) P (5) RMP (Ave, Std) (6) Slope (Ave, Std) � Rising Slope: Slope from bottom to peak � Falling Slope: Slope from peak to bottom � APD90 PWD 90 0% - 10%, 10% - 90%, 20% - 80%, 30% - 70% (7) Integration (Ave, Std) (8) - (16) PWD (10% - 90%) [ms] (Ave, Std)
Use ¡our ¡discoveries ¡to ¡advance ¡yours hERG/I Kr blocker
Use our discoveries to advance yours Astemizole hERG Blocker
5 min FDSS µ Cell - Astemizole vehicle control 41 nM 370 nM
30 min FDSS µ Cell - Astemizole vehicle control 4.57 nM 13.7 nM
30 min FDSS µ Cell - Astemizole 41 nM 123 nM 370 nM
Use our discoveries to advance yours Data Analysis with the Wave Checker Module Astemizole
FDSS µ Cell - Astemizole Wave Checker Module
FDSS µ Cell - Astemizole
FDSS µ Cell - Astemizole
FDSS µ Cell - Astemizole export of text file format
FDSS µ Cell - Astemizole
FDSS µ Cell - Astemizole
FDSS µ Cell - Astemizole
FDSS µ Cell - Astemizole 45,00# 14,00# 40,00# average&falling&slope&[RFU/ms]& 12,00# bea$ng'frequency'[bpm]' 35,00# baseline# 10,00# baseline# 30,00# 5#min# 5#min# 8,00# 25,00# 10#min# 10#min# 20,00# 6,00# 15#min# 15#min# 15,00# 4,00# 20#min# 20#min# 10,00# 2,00# 25#min# 25#min# 5,00# 30#min# 30#min# 0,00# 0,00# 10000,00# 3333,33# 1111,11# 370,37# 123,46# 41,15# 13,72# 4,57# 1,52# 0,51# Control# 35#min# 10000# 3333# 1111# 370# 123# 41# 14# 5# 2# 1# Control# 35#min# concentra$on'[nM]' concentra7on&[nM]&
FDSS µ Cell - Astemizole 18000,00# 14000,00# 16000,00# average&peak&width&60%&[ms]& 12000,00# 14000,00# average&peak&width&90%&[ms]& 10000,00# baseline# 12000,00# baseline# 5#min# 8000,00# 10000,00# 5#min# 10#min# 6000,00# 10#min# 8000,00# 15#min# 15#min# 4000,00# 6000,00# 20#min# 20#min# 4000,00# 2000,00# 25#min# 25#min# 30#min# 2000,00# 0,00# 30#min# 35#min# 10000,00# 3333,33# 1111,11# 370,37# 123,46# 41,15# 13,72# 4,57# 1,52# 0,51# Control# 0,00# 35#min# 10000,00# 3333,33# 1111,11# 370,37# 123,46# 41,15# 13,72# 4,57# 1,52# 0,51# Control# concentra8on&[nM]& concentra8on&[nM]& 14000,00# 14000,00# average&peak&width&80%&[ms]& 12000,00# 12000,00# average&peak&width&70%&[ms]& 10000,00# 10000,00# baseline# baseline# 5#min# 8000,00# 8000,00# 5#min# 10#min# 10#min# 6000,00# 6000,00# 15#min# 15#min# 4000,00# 4000,00# 20#min# 20#min# 2000,00# 25#min# 25#min# 2000,00# 30#min# 0,00# 30#min# # # # # # # # # # # # 35#min# 0 3 1 7 6 5 2 7 2 1 l o 0,00# 0 3 1 3 4 1 7 5 5 5 r , , , , , , , , , , t 35#min# 0 3 1 0 3 1 4 1 0 3 n 0 3 1 7 2 4 1 # # # # # # # # # # # o 0 3 1 7 6 5 2 7 2 1 l 0 3 1 3 1 o 0 3 1 3 4 1 7 5 5 5 C r 0 3 1 , , , , , , , , , , t 0 3 1 0 3 1 3 4 1 0 n 1 0 3 1 7 2 4 1 o 0 3 1 3 1 C 0 3 1 1 concentra8on&[nM]& concentra8on&[nM]&
Use our discoveries to advance yours Dofetilide hERG Blocker
5 min FDSS µ Cell - Dofetilide vehicle control 24.7 nM 222 nM
30 min FDSS µ Cell - Dofetilide vehicle control 24.7 nM
FDSS µ Cell - Dofetilide 70.00# 60.00# bea$ng'frequency'[bpm]' 50.00# baseline# 40.00# 5#min# 10#min# 30.00# 15#min# 20#min# 20.00# 25#min# 10.00# 30#min# 35#min# 0.00# # # # # # # # # # # # # l 3 0 0 1 4 3 9 7 2 7 0 o 0 1 3 9 7 2 6 0 2 6 0 r t . . . . . . . . . . . 0 0 0 0 2 8 4 4 2 6 n 0 2 7 2 6 0 o 2 6 0 C 2 concentra$on'[nM]' 10.00# 35.00# 9.00# average&falling&slope&[RFU/ms]& 30.00# 8.00# average&rising&slope&[RFU/ms]& 7.00# 25.00# baseline# 6.00# baseline# 20.00# 5#min# 5.00# 5#min# 10#min# 15.00# 10#min# 4.00# 15#min# 15#min# 3.00# 10.00# 20#min# 20#min# 2.00# 25#min# 5.00# 1.00# 25#min# 30#min# 0.00# 0.00# 30#min# Control# 0.03# 0.10# 0.30# 0.91# 2.74# 8.23# 24.69# 74.07# 222.22# 666.67# 2000.00# # # # # # # # # # # # # l 3 0 0 1 4 3 9 7 2 7 0 o 0 1 3 9 7 2 6 0 2 6 0 r . . . . . . . . . . . t 0 0 0 0 2 8 4 4 2 6 0 n 2 7 2 6 0 o 2 6 0 C 2 concentra6on&[nM]& concentra7on&[nM]&
FDSS µ Cell - Dofetilide 800.00# 1600.00# 700.00# 1400.00# average&peak&width&30%&[ms]& average&peak&width&50%&[ms]& 600.00# 1200.00# baseline# baseline# 500.00# 1000.00# 5#min# 5#min# 400.00# 800.00# 10#min# 10#min# 300.00# 600.00# 15#min# 15#min# 200.00# 400.00# 20#min# 20#min# 100.00# 200.00# 25#min# 25#min# 0.00# 0.00# 30#min# 30#min# Control# 0.91# 24.69# 74.07# 222.22# 666.67# 2000.00# 0.03# 0.10# 0.30# 2.74# 8.23# Control# 0.03# 0.10# 0.30# 0.91# 2.74# 8.23# 24.69# 74.07# 222.22# 666.67# 2000.00# concentra8on&[nM]& concentra8on&[nM]& 14000.00# 5000.00# 4500.00# average&peak&width&70%&[ms]& 12000.00# average&peak&width&90%&[ms]& 4000.00# 10000.00# 3500.00# baseline# baseline# 3000.00# 8000.00# 5#min# 5#min# 2500.00# 10#min# 6000.00# 10#min# 2000.00# 15#min# 15#min# 1500.00# 4000.00# 1000.00# 20#min# 20#min# 2000.00# 500.00# 25#min# 25#min# 0.00# 0.00# 30#min# 30#min# Control# 0.03# 0.10# 0.30# 0.91# 2.74# 8.23# 24.69# 74.07# 222.22# 666.67# 2000.00# Control# 0.03# 0.10# 0.30# 0.91# 2.74# 8.23# 24.69# 74.07# 222.22# 666.67# 2000.00# concentra8on&[nM]& concentra8on&[nM]&
FDSS µCell - Clustering of Compounds Confidential
Outlook
Outlook - Hamamatsu FDSS 7000EX Camera for fast recording of fluorescence and luminescence.
Outlook Evaluation of different kinds of fluorescent calcium and membrane potential dyes for the Cor.4U Cardiomyocytes Establishment of cardiac cytotoxicity/viability assay Combination of different luminescence assays viability cell death detection apoptosis
Dopaminergic and Sensory Neurons
Patch Clamp of hiPS-derived Dopamineric Neurons Manual current clamp recording Manual voltage clamp recording of spontaneous action potentials of sodium currents 0.06 0.04 0.02 0.00 U[V] -0.02 -0.04 -0.06 -0.08 0 2 4 6 8 10 12 T[s] Data was kindly provided by PoreGenic GmbH, Rostock, Germany
Patch Clamp of hiPS-derived Peripheral Neurons Manual voltage clamp recording of sodium currents raw data I/V diagram 1.00E-009 0.00E+000 -1.00E-009 I[A] -2.00E-009 -3.00E-009 -4.00E-009 -0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 0.08 U[V] Data was kindly provided by PoreGenic GmbH, Rostock, Germany
Recommend
More recommend